Lunar Flashlight science ground and flight measurements and operations using a multi-band laser reflectometer

B. A. Cohen(Marshall Space Flight Center), W. Jud Ready, R. Glenn Sellar(Jet Propulsion Laboratory), Marilyn Braojos Gutierrez, D. A. Paige(University of California, Los Angeles), Philippe C. Adell(Jet Propulsion Laboratory), Ryan R. Petersburg(Johns Hopkins University Applied Physics Laboratory), P. O. Hayne(Jet Propulsion Laboratory), Daniel R. Cremons(Goddard Space Flight Center), Valeria Lopez Robles(Planetary Science Institute), Mark Sullivan(Gilead Sciences (United States)), J. M. Camacho(Southern Methodist University), Nathan Cheek(Jet Propulsion Laboratory), M. Starr, Mahmood Bagheri(Jet Propulsion Laboratory), Tyler Horvath(University of California, Los Angeles), Quentin P. Vinckier(Jet Propulsion Laboratory), B. T. Greenhagen(Johns Hopkins University Applied Physics Laboratory), Michael J. Hauge, Robert G. Lammens, Patrick Russell(Planetary Science Institute), John D. Baker(Children's Hospital of Michigan), Chad P. Ryan(Jet Propulsion Laboratory), Jessica Ban(Planetary Science Institute), Dillan A. McDonald, Christina M. Kneis, E. Glenn Lightsey(Georgia Institute of Technology), Christopher G. Payne(Jet Propulsion Laboratory), Collin W. Gonzalez(The Aerospace Corporation)
Icarus
February 29, 2024
Cited by 5


Related Papers

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
|Gastroenterology|2003|554
Mars 2020 Mission Overview
|Space Science Reviews|2020|535